Product Name :
Burixafor hydrobromide
Description:
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent antagonist of CXCR4 and a well anti-angiogenic drug that is of potential value in treating choroid neovascularization. Burixafor hydrobromide (TG-0054 hydrobromide) mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction.
CAS:
1191450-19-7
Molecular Weight:
647.63
Formula:
C27H52BrN8O3P
Chemical Name:
(2-{4-[6-amino-2-({[4-({[3-(cyclohexylamino)propyl]amino}methyl)cyclohexyl]methyl}amino)pyrimidin-4-yl]piperazin-1-yl}ethyl)phosphonic acid hydrobromide
Smiles :
Br.NC1=CC(=NC(NCC2CCC(CNCCCNC3CCCCC3)CC2)=N1)N1CCN(CCP(O)(O)=O)CC1
InChiKey:
ZXUVXYNBMUFEMK-UHFFFAOYSA-N
InChi :
InChI=1S/C27H51N8O3P.BrH/c28-25-19-26(35-15-13-34(14-16-35)17-18-39(36,37)38)33-27(32-25)31-21-23-9-7-22(8-10-23)20-29-11-4-12-30-24-5-2-1-3-6-24;/h19,22-24,29-30H,1-18,20-21H2,(H2,36,37,38)(H3,28,31,32,33);1H
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent antagonist of CXCR4 and a well anti-angiogenic drug that is of potential value in treating choroid neovascularization.{{Osilodrostat} web|{Osilodrostat} Mineralocorticoid Receptor|{Osilodrostat} Protocol|{Osilodrostat} In Vivo|{Osilodrostat} supplier|{Osilodrostat} Autophagy} Burixafor hydrobromide (TG-0054 hydrobromide) mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction.{{Bumetanide} site|{Bumetanide} Membrane Transporter/Ion Channel|{Bumetanide} Biological Activity|{Bumetanide} In Vitro|{Bumetanide} custom synthesis|{Bumetanide} Epigenetic Reader Domain} |Product information|CAS Number: 1191450-19-7|Molecular Weight: 647.PMID:35126464 63|Formula: C27H52BrN8O3P|Chemical Name: (2-{4-[6-amino-2-({[4-({[3-(cyclohexylamino)propyl]amino}methyl)cyclohexyl]methyl}amino)pyrimidin-4-yl]piperazin-1-yl}ethyl)phosphonic acid hydrobromide|Smiles: Br.NC1=CC(=NC(NCC2CCC(CNCCCNC3CCCCC3)CC2)=N1)N1CCN(CCP(O)(O)=O)CC1|InChiKey: ZXUVXYNBMUFEMK-UHFFFAOYSA-N|InChi: InChI=1S/C27H51N8O3P.BrH/c28-25-19-26(35-15-13-34(14-16-35)17-18-39(36,37)38)33-27(32-25)31-21-23-9-7-22(8-10-23)20-29-11-4-12-30-24-5-2-1-3-6-24;/h19,22-24,29-30H,1-18,20-21H2,(H2,36,37,38)(H3,28,31,32,33);1H|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: H2O : 50 mg/mL (65.02 mM; Need ultrasonic).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|